EVOMMUNE INC (EVMN:NYSE)
$25.51 -3.14 (-10.9599%)
Analysed EVOMMUNE INC (EVMN:NYSE) News Sources
Evommune's Chronic-Hives Drug May See Wider Use If Trial Succeeds, RBC Says
10-04-2026
yahoo.com
Biotech’s IPO comeback; Trump’s tariff loophole for pharma
10-04-2026
pharmavoice.com
Evommune bucked biotech IPO drought and is focused on the long game
07-04-2026
pharmavoice.com
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine
06-04-2026
yahoo.com
Apogee strengthens case for longer-lasting eczema drug
23-03-2026
biopharmadive.com
Evommune Stock Sees RS Rating Rise To 91
18-03-2026
yahoo.com
Block upgraded, Starbucks downgraded: Wall Street's top analyst calls
18-03-2026
yahoo.com
1 Under‑the‑Radar Biotech to Buy for Potential 10X Growth in the Next Decade
10-03-2026
fool.com
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
05-03-2026
yahoo.com
Evommune CEO Luis Peña Reveals What’s Behind Company’s Post-IPO Success
25-02-2026
yahoo.com
What is the current price of EVOMMUNE INC (EVMN:NYSE)?
The current price of EVOMMUNE INC (EVMN:NYSE) is $25.51.
EVOMMUNE INC (EVMN:NYSE) absolute price change since previous trading day?
The absolute price change of EVOMMUNE INC (EVMN:NYSE) since the previous trading day is $-3.14.
EVOMMUNE INC (EVMN:NYSE) percentage price change since previous trading day?
The percentage price change of EVOMMUNE INC (EVMN:NYSE) since the previous trading day is -10.9599%.
What is the most recent average sentiment score for EVOMMUNE INC (EVMN:NYSE)?
The most recent average sentiment score for EVOMMUNE INC (EVMN:NYSE) is 40 out of 100.
What is the most recent average sentiment for EVOMMUNE INC (EVMN:NYSE)?
The most recent sentiment for EVOMMUNE INC (EVMN:NYSE) is .
SEC-8K** Filing Available For EVOMMUNE INC (EVMN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.